CLINICAL_TRIALS
trial_result
· 2013-01-17
Clinical Trial Update: Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma [Phase 2]
Summary
This document reports the results of a Phase 2 trial of dasatinib in patients with previously treated malignant mesothelioma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Malignant Mesothelioma | Phase 2 | Status: COMPLETED | Results posted: 2013-01-17